First National Bank of Mount Dora Trust Investment Services cut its holdings in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) by 30.5% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 17,292 shares of the financial services provider's stock after selling 7,585 shares during the quarter. First National Bank of Mount Dora Trust Investment Services' holdings in Marsh & McLennan Companies were worth $4,220,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Norges Bank purchased a new position in Marsh & McLennan Companies in the 4th quarter valued at about $1,236,186,000. Stifel Financial Corp lifted its holdings in Marsh & McLennan Companies by 551.0% in the fourth quarter. Stifel Financial Corp now owns 2,224,932 shares of the financial services provider's stock valued at $472,599,000 after acquiring an additional 1,883,146 shares during the last quarter. Amundi grew its holdings in shares of Marsh & McLennan Companies by 81.1% during the 4th quarter. Amundi now owns 4,072,976 shares of the financial services provider's stock worth $860,824,000 after purchasing an additional 1,823,807 shares during the period. GAMMA Investing LLC raised its position in Marsh & McLennan Companies by 32,120.9% in the first quarter. GAMMA Investing LLC now owns 1,515,670 shares of the financial services provider's stock valued at $369,869,000 after purchasing an additional 1,510,966 shares during the period. Finally, Raymond James Financial Inc. acquired a new stake in shares of Marsh & McLennan Companies during the fourth quarter worth about $207,278,000. 87.99% of the stock is owned by institutional investors and hedge funds.
Marsh & McLennan Companies Trading Down 0.4%
NYSE:MMC traded down $0.82 during trading hours on Wednesday, hitting $217.30. 2,938,286 shares of the company were exchanged, compared to its average volume of 1,934,557. The company has a fifty day simple moving average of $226.81 and a 200 day simple moving average of $225.64. Marsh & McLennan Companies, Inc. has a one year low of $207.21 and a one year high of $248.00. The stock has a market capitalization of $107.07 billion, a price-to-earnings ratio of 26.53, a price-to-earnings-growth ratio of 2.70 and a beta of 0.83. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.44.
Marsh & McLennan Companies (NYSE:MMC - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The financial services provider reported $3.06 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.02 by $0.04. The company had revenue of $6.70 billion for the quarter, compared to analysts' expectations of $7.08 billion. Marsh & McLennan Companies had a net margin of 16.60% and a return on equity of 32.60%. During the same quarter in the prior year, the firm earned $2.89 EPS. Sell-side analysts expect that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current fiscal year.
Insiders Place Their Bets
In related news, CEO Dean Michael Klisura sold 9,569 shares of the firm's stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $245.00, for a total transaction of $2,344,405.00. Following the completion of the sale, the chief executive officer now owns 20,935 shares of the company's stock, valued at $5,129,075. This trade represents a 31.37% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Paul Beswick sold 2,237 shares of the firm's stock in a transaction dated Thursday, April 3rd. The shares were sold at an average price of $246.00, for a total transaction of $550,302.00. Following the sale, the senior vice president now directly owns 13,522 shares in the company, valued at approximately $3,326,412. The trade was a 14.20% decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.35% of the company's stock.
Wall Street Analyst Weigh In
Several research analysts have commented on MMC shares. Barclays boosted their price target on shares of Marsh & McLennan Companies from $246.00 to $249.00 and gave the stock an "equal weight" rating in a report on Friday, April 11th. Wells Fargo & Company raised their price target on Marsh & McLennan Companies from $223.00 to $232.00 and gave the stock an "equal weight" rating in a research report on Thursday, April 10th. Keefe, Bruyette & Woods cut their target price on Marsh & McLennan Companies from $220.00 to $215.00 and set an "underperform" rating on the stock in a research report on Monday, April 21st. Redburn Atlantic initiated coverage on Marsh & McLennan Companies in a research note on Tuesday, March 25th. They set a "buy" rating and a $281.00 target price for the company. Finally, Jefferies Financial Group upped their target price on Marsh & McLennan Companies from $237.00 to $244.00 and gave the company a "hold" rating in a report on Friday, April 11th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and five have issued a buy rating to the company. According to data from MarketBeat.com, Marsh & McLennan Companies currently has an average rating of "Hold" and an average target price of $241.93.
Read Our Latest Report on Marsh & McLennan Companies
Marsh & McLennan Companies Profile
(
Free Report)
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Read More

Before you consider Marsh & McLennan Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marsh & McLennan Companies wasn't on the list.
While Marsh & McLennan Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.